MedPath

LY-4006896

Generic Name
LY-4006896

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Phase 1
Recruiting
Conditions
Parkinson Disease
Interventions
Drug: Placebo
First Posted Date
2025-02-05
Last Posted Date
2025-04-17
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
127
Registration Number
NCT06809400
Locations
🇺🇸

Collaborative Neuroscience Network - CNS, Los Alamitos, California, United States

🇺🇸

PPD Development, LP, Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath